International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 4 , Pages 980-987 , 15 March 2009

Radiation-Induced Cardiac Toxicity After Therapy for Breast Cancer: Interaction Between Treatment Era and Follow-Up Duration

  • Senem Demirci, M.D.

      Affiliations

    • Department of Radiation Oncology, Ege University School of Medicine, Izmir, Turkey
    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC
    • ,
  • Jiho Nam, M.D.

      Affiliations

    • Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC
    • ,
  • Jessica L. Hubbs, M.S.

      Affiliations

    • Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC
    • ,
  • Thu Nguyen, B.A.

      Affiliations

    • Department of Epidemiology, University of North Carolina School of Public Health, Chapel Hill, NC
    • ,
  • Lawrence B. Marks, M.D.

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC
    • Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC
    • Corresponding Author InformationReprint requests to: Lawrence B. Marks, M.D., Department of Radiation Oncology, University of North Carolina School of Medicine, Campus Box 7512, Chapel Hill, NC 27599-7512. Tel: (919) 966-0400; Fax: (919) 966-7681

Received 18 September 2008 ,Revised 5 November 2008 ,Accepted 14 November 2008.

References 

  1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241
  2. Lichter AS, Lippman ME, Danforth DN, et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: A randomized trial at the National Cancer Institute. J Clin Oncol. 1992;10:976–983
  3. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143–1150
  4. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b trial. N Engl J Med. 1997;337:949–955
  5. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641–1648
  6. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962
  7. Whelan TJ, Julian J, Wright J, et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol. 2000;18:1220–1229
  8. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet. 2000;355:1757–1770
  9. Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994;12:447–453
  10. Houghton J, Baum M, Haybittle JL The Closed Trials Working Party of the CRC Breast Cancer Trials Group. Role of radiotherapy following total mastectomy in patients with early breast cancer. World J Surg. 1994;18:117–122
  11. Jones JM, Ribeiro GG. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol. 1989;40:204–208
  12. Rutqvist LE, Lax I, Fornander T, et al. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys. 1992;22:887–896
  13. Rutqvist LE, Johansson H. Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer. 1990;61:866–868
  14. Paszat LF, Mackillop WJ, Groome PA, et al. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the Surveillance, Epidemiology, and End Results cancer registries. J Clin Oncol. 1998;16:2625–2631
  15. Haybittle JL, Brinkley D, Houghton J, et al. Postoperative radiotherapy and late mortality: Evidence from the Cancer Research Campaign trial for early breast cancer. BMJ. 1989;298:1611–1614
  16. Nixon AJ, Manola J, Gelman R, et al. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol. 1998;16:1374–1379
  17. Paszat LF, Vallis KA, Benk VM, et al. A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer. Radiother Oncol. 2007;82:294–300
  18. Doyle JJ, Neugut AI, Jacobson JS, et al. Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients. Int J Radiat Oncol Biol Phys. 2007;68:82–93
  19. Darby SC, McGale P, Taylor CW, et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6:557–565
  20. Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, et al. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol. 1999;51:35–42
  21. Darby S, McGale P, Peto R, et al. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: Nationwide cohort study of 90 000 Swedish women. BMJ. 2003;326:256–257
  22. Harris EE, Correa C, Hwang WT, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol. 2006;24:4100–4106
  23. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087–2106
  24. Perez CA, Halperin EC. Principles and practice of radiation oncology. 4th ed.. Philadelphia: Lippincott Williams & Wilkins; 2004;
  25. Sheskin D. Handbook of parametric and nonparametric statistical procedures. 4th ed.. Boca Raton, FL: Chapman & Hall/CRC; 2007;
  26. Katz MH. Multivariable analysis: A practical guide for clinicians. 2nd ed.. Cambridge: Cambridge University Press; 2006;
  27. Davies HT, Crombie IK, Tavakoli M. When can odds ratios mislead?. BMJ. 1998;316:989–991
  28. Altman DG, Deeks JJ, Sackett DL. Odds ratios should be avoided when events are common. BMJ. 1998;317:1318
  29. Szklo M, Nieto FJ. Epidemiology: Beyond the basics. Gaithersburg, MD: Aspen; 2000;
  30. Patt DA, Goodwin JS, Kuo YF, et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol. 2005;23:7475–7482
  31. Giordano SH, Kuo YF, Freeman JL, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005;97:419–424
  32. Gyenes G, Rutqvist LE, Liedberg A, et al. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol. 1998;48:185–190
  33. Hojris I, Overgaard M, Christensen JJ, et al. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Lancet. 1999;354:1425–1430
  34. Rutqvist LE, Liedberg A, Hammar N, et al. Myocardial infarction among women with early-stage breast cancer treated with conservative surgery and breast irradiation. Int J Radiat Oncol Biol Phys. 1998;40:359–363
  35. Pinder MC, Duan Z, Goodwin JS, et al. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol. 2007;25:3808–3815
  36. Roychoudhuri R, Robinson D, Putcha V, et al. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: A population-based study. BMC Cancer. 2007;7:9
  37. Paszat LF, Mackillop WJ, Groome PA, et al. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: A population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys. 1999;43:755–762
  38. Hooning MJ, Aleman BM, van Rosmalen AJ, et al. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Int J Radiat Oncol Biol Phys. 2006;64:1081–1091
  39. Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99:365–375
  40. Borger JH, Hooning MJ, Boersma LJ, et al. Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: The role of irradiated heart volume. Int J Radiat Oncol Biol Phys. 2007;69:1131–1138
  41. Host H, Brennhovd IO, Loeb M. Postoperative radiotherapy in breast cancer—Long-term results from the Oslo study. Int J Radiat Oncol Biol Phys. 1986;12:727–732
  42. Vallis KA, Pintilie M, Chong N, et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol. 2002;20:1036–1042
  43. Marhin W, Wai E, Tyldesley S. Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer. Int J Radiat Oncol Biol Phys. 2007;69:483–489
  44. Gyenes G, Fornander T, Carlens P, et al. Morbidity of ischemic heart disease in early breast cancer 15–20 years after adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 1994;28:1235–1241

 Portions of this work were made possible by grants from the International Atomic Energy Agency and the Turkish Association of Radiation Oncology.

 Portions of this work were presented at the 44th Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, May 30–June 3, 2008.

 Conflict of interest: S. Demirci was funded by grants from the International Atomic Energy Agency and Turkish Association of Radiation Oncology; L. B. Marks received honoraria from Varian Medical Systems and grant support from the National Institutes of Health, the Lance Armstrong Foundation, and the Department of Defense.

PII: S0360-3016(08)03803-0

doi: 10.1016/j.ijrobp.2008.11.016

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 4 , Pages 980-987 , 15 March 2009

Article Tools

* Image Usage & Resolution